Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glazer, M.
Right arrow Articles by Berkman, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glazer, M.
Right arrow Articles by Berkman, N.
(Chest. 2000;117:279-282.)
© 2000 American College of Chest Physicians

The Role of BAL in the Diagnosis of Pulmonary Mucormycosis*

Mendel Glazer, MD; Samir Nusair, MD; Raphael Breuer, MD; Joel Lafair, MD; Yoav Sherman, MD and Neville Berkman, MBBCh

* From the Institute of Pulmonology (Drs. Glazer, Nusair, Breuer, Lafair, and Berkman) and the Department of Pathology (Dr. Sherman), Hadassah University Hospital, Jerusalem, Israel.

Correspondence to: Neville Berkman, MBBCh, Institute of Pulmonology, Hadassah University Hospital, PO Box 12000, Jerusalem, Israel, 91120.

Five patients with pulmonary mucormycosis diagnosed during life are described. All had underlying predisposing conditions: either posttransplant or hematologic malignancies. In all cases, the diagnosis was made using fiberoptic bronchoscopy. In three patients, BAL was diagnostic. In two of these patients, the diagnosis was made by identifying the typical hyphae of mucormycosis in the BAL fluid alone. Transbronchial biopsy was diagnostic in three patients. Treatment was based on IV antifungal chemotherapy together with surgical removal of involved lung tissue whenever feasible. The clinical outcome of these patients was dismal and was determined primarily by the underlying condition.

Key Words: BAL • immunocompromised • mucormycosis • neutropenia




This article has been cited by other articles:


Home page
 Eur Respir JHome page
S. Nusair, R. Breuer, M.Y. Shapira, N. Berkman, and R. Or
Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation
Eur. Respir. J., March 1, 2004; 23(3): 440 - 445.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.